Mucins are members of an expanding family of large multifunctional glycoproteins. Pancreatic mucins have important biological functions, including the protection, lubrication, and moisturisation of the surfaces of epithelial tissues lining ductal structures within the pancreas. Several lines of evidence support the notion that deregulated mucin production is a hallmark of inflammatory and neoplastic disorders of the pancreas. Herein, we discuss the factors that contribute to the lethality of pancreatic cancer as well as the key role played by mucins, particularly MUC1 and MUC4, in the development and progression of the disease. Aspects pertaining to the aberrant expression and glycosylation of mucins are discussed, with special emphasis on ...
MUC1 is a heavily glycosylated transmembrane glycoprotein which is overexpressed and aberrantly glyc...
MUC16 (CA125) belongs to a family of high-molecular weight O-glycosylated proteins known as mucins. ...
BACKGROUND: A major obstacle to the successful management of pancreatic cancer is to acquire resista...
International audiencePancreatic cancer is characterized by an often dramatic outcome (five year sur...
International audiencePancreatic cancer is characterized by an often dramatic outcome (five year sur...
International audiencePancreatic cancer is characterized by an often dramatic outcome (five year sur...
Pancreatic cancer is characterized by an often dramatic outcome (five year survival < 5%) related to...
BACKGROUND: Pancreatic cancer (PC) is a lethal malignancy primarily driven by activated Kras mutatio...
Mucins are high molecular weight glycoproteins and have critical functions in protecting epithelial ...
MUC4 is a type-1 transmembrane glycoprotein and is overexpressed in many carcinomas. It is a heterod...
Secretory mucin MUC5AC is an extensively glycosylated high molecular weight protein that forms a pol...
MUC4 is highly expressed in human pancreatic tumours and pancreatic tumour cell lines, but is minima...
Mucins are high molecular weight O-glycoproteins that are predominantly expressed at the apical surf...
Mucins are high molecular weight O-glycoproteins that are predominantly expressed at the apical surf...
Mucin-5AC (MUC5AC) is a heavily glycosylated gel-forming secreted mucin with a reliable prognostic v...
MUC1 is a heavily glycosylated transmembrane glycoprotein which is overexpressed and aberrantly glyc...
MUC16 (CA125) belongs to a family of high-molecular weight O-glycosylated proteins known as mucins. ...
BACKGROUND: A major obstacle to the successful management of pancreatic cancer is to acquire resista...
International audiencePancreatic cancer is characterized by an often dramatic outcome (five year sur...
International audiencePancreatic cancer is characterized by an often dramatic outcome (five year sur...
International audiencePancreatic cancer is characterized by an often dramatic outcome (five year sur...
Pancreatic cancer is characterized by an often dramatic outcome (five year survival < 5%) related to...
BACKGROUND: Pancreatic cancer (PC) is a lethal malignancy primarily driven by activated Kras mutatio...
Mucins are high molecular weight glycoproteins and have critical functions in protecting epithelial ...
MUC4 is a type-1 transmembrane glycoprotein and is overexpressed in many carcinomas. It is a heterod...
Secretory mucin MUC5AC is an extensively glycosylated high molecular weight protein that forms a pol...
MUC4 is highly expressed in human pancreatic tumours and pancreatic tumour cell lines, but is minima...
Mucins are high molecular weight O-glycoproteins that are predominantly expressed at the apical surf...
Mucins are high molecular weight O-glycoproteins that are predominantly expressed at the apical surf...
Mucin-5AC (MUC5AC) is a heavily glycosylated gel-forming secreted mucin with a reliable prognostic v...
MUC1 is a heavily glycosylated transmembrane glycoprotein which is overexpressed and aberrantly glyc...
MUC16 (CA125) belongs to a family of high-molecular weight O-glycosylated proteins known as mucins. ...
BACKGROUND: A major obstacle to the successful management of pancreatic cancer is to acquire resista...